| "I enjoy the creative process of building compelling ideas and concepts into sustainable, productive companies. From my roots as an evolutionary biologist, I view the growth of companies similarly—always in a dynamic state of flux and requiring timely resources and talent to continually evolve. It is immensely gratifying to cast people, technology, capital and a bit of luck together to create something that has never existed before into a living, organic entity focused on what I consider to be a worthy cause—solving the scourges of human disease. It doesn't get any better than this." |
|
|
R. Dana Ono, PhD — Managing Director, Life Sciences
dono@vimac.com Dana's experience includes over 20 years of senior management in public and private biotech companies. Most recently, he was a co-founder, President and CEO of IntraImmune Therapies, Inc., a biotechnology company which he sold to Abgenix, Inc. (Nasdaq:ABGX) in 2000. Prior to heading IntraImmune, he was founder and principal manager of several successful early stage biotech companies in the Boston area.
|
 |
| |
|
Background
Throughout his career, Dana has been engaged in the strategic planning, product management, technology acquisition and commercial development of biotech startups. A founding director of the Massachusetts Biotechnology Council, Inc., Dana is a frequent spokesperson for the biotechnology industry. He has authored a number of scientific articles and edited the book, "The Business of Biotechnology—From the Bench to the Street."
Education
|